b.correia
TL2 · Nijmegen
Contributes reviews on supplier material. Based in Nijmegen.
Joined 14 February 2025 · last posted 1d
84 posts, newest first. Showing up to 150.
-
Revisiting: Can a home kit substitute for a laboratory report? A careful no Replied, post #57 · Analytics › Home & field testing · 27 Jul 2026 · 4 likes Building on post #56 rather than restating it. Quantitation at home is the part that does not survive scrutiny. Precision adequate to distinguish 96 from 98 per cent…
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #75 · Access › International · 12 Jul 2026 · 1 like Country-by-country legality: compound approval and legal status differ substantially by jurisdiction. Semaglutide approved in the United States and European Union;…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #69 · Analytics › Impurities & related substances · 12 Jul 2026 · 2 likes Off-target structures: if the sequence synthesis goes wrong, a completely different amino acid can be incorporated. The resulting off-target peptide is a structural…
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #12 · Access › Insurance & coverage · 9 Jul 2026 · 1 like Marking my uncertainty on Prior authorisation explicitly. I am confident about the direction, much less confident about the size, and not confident at all that it…
-
What is genuinely unknown about long-term amylin agonism Replied, post #10 · Compounds › Cagrilintide & amylin analogues · 7 Jul 2026 · 0 likes Cagrilintide molecular characteristics: it is a synthetic amylin analogue, substituted to prevent the amyloidogenicity of human amylin. The sequence is short and…
-
Restarting after a long gap: what the labelling implies Replied, post #13 · Practice › Dosing & titration · 5 Jul 2026 · 32 likes The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose strictly between them is off-label by definition. Some people compute it anyway. The…
-
What to include when your question involves a laboratory result — a second dataset Replied, post #3 · Start Here › How to Ask · 5 Jul 2026 · 33 likes Second this, and I would have said it less carefully.
-
Pages past their review date, listed — does this still hold? Replied, post #33 · Meta › Wiki maintenance · 1 Jul 2026 · 0 likes Post #29 put the caveat in the right place and I want to underline it. Reporting an inconsistency between two maintained pages rather than an error in either. They use…
-
What a certificate commits its issuer to — the long version Replied, post #19 · Analytics › COA interpretation · 30 Jun 2026 · 0 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
-
Personal or family history of medullary thyroid carcinoma Replied, post #7 · Safety › Contraindications · 22 Jun 2026 · 1 like On post #5 — agreed on the reasoning, with one qualification. Allergy to the specific compound: true allergy is rare but possible. Any prior allergic reaction to the…
-
Pooling trials with different estimands Replied, post #33 · Evidence › Meta-analyses · 18 Jun 2026 · 4 likes Coming back to post #29, because the follow-up matters more than the original answer. Worth stating the null on pooling trials with different estimands before we…
-
Review: a draft on reconstitution arithmetic, with objections — one year on Replied, post #29 · Documentation › Doc review · 17 Jun 2026 · 13 likes I read post #25 twice before replying, because I had assumed the opposite. Where content is lifted from a topic, attribution should be in the document rather than only…
-
Primary endpoint hierarchies and why order matters — one year on Replied, post #14 · Evidence › Trials · 13 Jun 2026 · 30 likes Adding the measurement that post #11 says would settle it. Where I would push back on the Primary endpoint hierarchies consensus is the confidence, not the direction.…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #10 · Start Here › Welcome · 7 Jun 2026 · 10 likes Trust levels accumulate over time and they give you access to small things like the ability to edit your own posts without a timestamp. They are not a status symbol and…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #133 · Compounds › Tirzepatide · 21 May 2026 · 1 like Worth separating two things that post #131 runs together. I read the earlier replies on 2.5 mg starting dose twice before writing this, because I had assumed the…
-
Transporting a vial for a weekend away — a second dataset Replied, post #46 · Practice › Storage & stability · 6 May 2026 · 20 likes Container choice matters: the material of the vial, the rubber closure, the fill volume all affect how quickly the contents degrade. Smaller fill volumes lose less to…
-
A plateau that disappeared when I changed how I measured Replied, post #31 · Outcomes › Progress reports · 10 Apr 2026 · 6 likes Plateau has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done that here yet.
-
Spike-and-recover accuracy for a peptide assay Replied, post #48 · Analytics › Method validation · 8 Apr 2026 · 12 likes Answering the question post #46 raises rather than the one it answers. Accuracy: the method measures what you intend to measure. For purity methods, this is tested by…
-
The "under review" status pill and when a moderator applies it Replied, post #57 · Evidence › Preprints · 6 Apr 2026 · 10 likes Preprints for speed: some important preliminary findings are posted as preprints to disseminate quickly. That speed is useful but comes at the cost of not yet having…
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #42 · Analytics › Mass spectrometry · 30 Mar 2026 · 13 likes Understood. Thank you for being specific about the limits of it.
-
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #56 · Practice › Side effects · 14 Mar 2026 · 15 likes On post #55 — agreed on the reasoning, with one qualification. The relationship between symptom burden and outcome is not what people assume. Feeling worse is not…
-
The lowest dose that does anything: is that a real question? Replied, post #87 · Practice › Dosing & titration · 7 Mar 2026 · 0 likes Confirming post #86 from a second method, which matters more than confirming it from a second person. Escalating before steady state means you are judging a dose you…
-
The lowest dose that does anything: is that a real question? Replied, post #62 · Practice › Dosing & titration · 5 Mar 2026 · 0 likes Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long half-life, which gives a slowly changing plasma level from a…
-
Cost per delivered dose, which is the number that matters Replied, post #53 · Access › Pricing · 2 Mar 2026 · 0 likes The most useful pricing posts here are the ones that show the arithmetic rather than the conclusion.
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #18 · Research Methods › N-of-1 designs · 26 Feb 2026 · 8 likes The best thing about this subcategory is that people post their protocols before their results. That order is what keeps it honest. Scoping that to what I have actually…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #107 · Clinical › Special populations · 22 Feb 2026 · 28 likes Post-surgical populations, particularly after procedures affecting the gastrointestinal tract, interact with a delayed-emptying mechanism in ways that need specialist…
-
Constipation management, with a dietitian's contribution Replied, post #32 · Practice › Side effects · 21 Feb 2026 · 0 likes I have three months of notes on constipation management and the honest summary is that the trend is real and the week-to-week numbers are noise. I nearly drew the…
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #7 · Sourcing › Red flags · 18 Feb 2026 · 0 likes On post #3 — agreed on the reasoning, with one qualification. The arithmetic on supplier is the easy part and it is where the errors are, which is an uncomfortable…
-
[2026 update] What a purity-only report leaves out Replied, post #28 · Sourcing › Independent verification · 17 Feb 2026 · 4 likes Fair, and the limits you put on it are the part I will remember.
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #28 · Practice › Dosing & titration · 16 Feb 2026 · 0 likes A titration plan written down in advance is easier to stick to and easier to abandon deliberately. An improvised one becomes a series of decisions made on the worst day…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #115 · Analytics › Mass spectrometry · 15 Feb 2026 · 15 likes Sample preparation for mass spectrometry can itself introduce modifications, particularly oxidation. A finding at trace level may be telling you about the preparation…
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #89 · Documentation › Wiki requests · 14 Feb 2026 · 1 like Post #87 put the caveat in the right place and I want to underline it. Say what would make the page wrong. A page whose failure conditions are stated is much easier to…
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #45 · Evidence › Study critique · 11 Feb 2026 · 2 likes Per-protocol and intention-to-treat analyses answer different questions and neither is the honest one by default. Reporting both is the practice worth insisting on.
-
Oral semaglutide bioavailability and its variability between people Replied, post #32 · Compounds › Oral incretins · 3 Feb 2026 · 1 like Narrowing post #31, because the general version has more than one answer. Anyone comparing published oral and injectable efficacy should check whether the comparison is…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #21 · Data & Tools › Datasets · 1 Feb 2026 · 1 like Post #18 is right about the mechanism and I think understates the practical bit. Publishing the raw records alongside the summary is what makes a dataset checkable. A…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #111 · Clinical › Special populations · 27 Jan 2026 · 4 likes The bit of Pregnancy and pregnancy planning that nobody enjoys is that the answer changes depending on what you are trying to decide with it. Say what the decision is…
-
[2026 update] What a purity-only report leaves out Started this topic · Sourcing › Independent verification · 12 Jan 2026 · 0 likes The question in the title: What a purity-only report leaves out I will give what I have already checked below so nobody repeats it. Structured report rather than an…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #7 · Outcomes › Body composition · 28 Dec 2025 · 3 likes The arithmetic in post #6 is right; the assumption feeding it is the part to check. Having read the whole Lean mass preservation thread before replying: the question in…
-
Liver enzymes drifting down and what that usually means Replied, post #37 · Clinical › Bloodwork · 16 Dec 2025 · 6 likes Glycaemic markers integrate over different periods. A point glucose and a longer-term marker disagreeing is not a contradiction; it is two different questions.
-
EU-wide position versus national implementation — what changed since Replied, post #10 · Regional › European Union · 14 Dec 2025 · 0 likes Parallel distribution is a real mechanism and produces packaging that looks unfamiliar for legitimate reasons.
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #73 · Analytics › Home & field testing · 8 Dec 2025 · 23 likes Answering the question post #69 raises rather than the one it answers. Nothing available at home distinguishes a correct sequence from a closely related incorrect one.…
-
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #93 · Compounds › Other compounds · 26 Nov 2025 · 12 likes Sequence verification came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the reconstruction.
-
What a regulator's shortage notice actually authorises — what changed since Replied, post #20 · Sourcing › Regulatory · 24 Nov 2025 · 2 likes Helpful, and short, which on this subject is harder than long.
-
Guidelines revision: what changed and why — one year on Replied, post #29 · Meta › Announcements · 26 Oct 2025 · 1 like Taking post #27 at face value and following it one step further. Worth saying publicly: stepping back cleanly and handing over is a service. Documents with an absent…
-
Amylin receptor signalling and satiety Replied, post #2 · Pharmacology › Receptor biology · 18 Oct 2025 · 0 likes Building on the opening post rather than restating it. Half-life extension by albumin binding through a fatty acid chain trades free fraction for duration. It is an…
-
Sleep quality changes during weight loss — what changed since Replied, post #29 · Wellbeing › Sleep · 16 Oct 2025 · 4 likes Fatigue during the day and poor sleep at night are different problems with different causes and get merged in most accounts here. Caveat: everything above assumes the…
-
Coming back to: Why quantitation is the hard part, not detection Replied, post #79 · Analytics › Home & field testing · 15 Oct 2025 · 0 likes Noted, and I have changed what I was going to do on the strength of it.
-
The anatomy of a question that gets answered within an hour — the long version Started this topic · Start Here › How to Ask · 14 Oct 2025 · 47 likes The anatomy of a question that gets answered within an hour — the long version Writing it up because I had to work it out twice and would rather nobody else did.…
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #88 · Compounds › Cagrilintide & amylin analogues · 5 Oct 2025 · 1 like Reconstitution at higher concentrations is worth avoiding for aggregation-prone material. The published formulation work generally uses lower concentrations than people…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #134 · Practice › Reconstitution · 28 Sep 2025 · 4 likes Write the reconstitution date and the concentration on the vial. Not on a note, on the vial. Every account here of a dosing error involving the wrong concentration…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #143 · Practice › Storage & stability · 17 Sep 2025 · 1 like Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear. Correct me on the…
-
Are there stupid questions here? A staff answer, at length Replied, post #149 · Start Here › Welcome · 4 Sep 2025 · 12 likes If you want a fast orientation, read three solved topics in the subcategory you care about. Solved means somebody said the answer worked, which is more signal than…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #45 · Practice › Administration · 3 Sep 2025 · 0 likes Angle of injection: 90 degrees into pinched tissue ensures subcutaneous placement. It is not always necessary and shallower angles can work, but 90 degrees into a small…
-
Second pass at: LOD and LOQ: definitions people get wrong Replied, post #17 · Analytics › Method validation · 27 Aug 2025 · 0 likes System suitability is the ongoing evidence that a validated method is still performing. Validation is done once; suitability is done every run, and it is the one that…
-
Micronutrient status when intake falls substantially Replied, post #21 · Clinical › Bloodwork · 1 Aug 2025 · 23 likes Picking up post #20: that is the part I would want checked first. My experience of micronutrient status contradicts the reply above. I am posting it as a data point…
-
What this community means by "a source", in practical terms Replied, post #41 · Start Here › Welcome · 20 Jul 2025 · 0 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Follow-up: Tracking intake honestly when appetite is absent Replied, post #90 · Nutrition & Training › Protein & intake · 14 Jun 2025 · 9 likes Useful. I had the fact and not the reason, which turns out to be the important half.
-
Coming back to: Getting a referral rather than a refusal Replied, post #57 · Clinical › Prescriber conversations · 11 Jun 2025 · 22 likes The claim about Getting a referral upthread is stronger than its source supports. I have read the source. The source says "associated with" and the post says "causes".
-
DXA precision and the least significant change for lean mass — the long version Replied, post #91 · Outcomes › Body composition · 24 May 2025 · 2 likes Bioelectric impedance analysis: less precise than DXA and strongly affected by hydration state. Not reliable for detecting month-to-month changes. Useful for trend over…
-
A well-designed study with a badly written abstract Replied, post #103 · Evidence › Study critique · 24 May 2025 · 11 likes Statistical significance and clinical importance are different and both are needed. A significant difference below the minimal important difference is a real finding of…
-
DXA precision and the least significant change for lean mass — the long version Replied, post #72 · Outcomes › Body composition · 21 May 2025 · 2 likes An update on my earlier DXA precision post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
-
The C-cell question: rodent findings and their human context Replied, post #18 · Compounds › Semaglutide · 19 May 2025 · 8 likes On the injection-day question: the labelling for licensed semaglutide allows the day to be changed provided at least two days separate the two injections. That interval…
-
Follow-up: Documentation that appears only after payment Replied, post #13 · Sourcing › Red flags · 22 Apr 2025 · 0 likes Reading this Documentation thread as someone who came in with a fixed view: the third and seventh replies moved me and the confident ones did not.
-
Retatrutide dose escalation in the published trials Replied, post #96 · Compounds › Retatrutide · 6 Apr 2025 · 0 likes Comparisons with tirzepatide are being made across trials rather than within one. Different populations, different durations, different endpoints; the effect sizes are…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #128 · Analytics › COA interpretation · 26 Mar 2025 · 0 likes That is the distinction I keep failing to hold on to. Written down now.
-
Charge states for a 4 kDa peptide, worked through Replied, post #70 · Analytics › Mass spectrometry · 10 Mar 2025 · 1 like Post #66 describes the usual case. This is about the unusual one. A note on scope: what I am saying about charge states applies to the case in the first post and I…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #28 · Practice › Reconstitution · 8 Mar 2025 · 5 likes Coming back to post #24, because the follow-up matters more than the original answer. Two people can reconstitute the same vial to different concentrations and both be…
-
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #13 · Compounds › Cagrilintide & amylin analogues · 24 Feb 2025 · 22 likes Coming back to post #9, because the follow-up matters more than the original answer. Gastric emptying: both amylin and GLP-1 slow it, through partly overlapping but…
-
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #16 · Compounds › Retatrutide · 18 Feb 2025 · 30 likes I came in to disagree and I am leaving without a disagreement.
-
Consistent declarations and why they matter more than clever ones Replied, post #24 · Sourcing › Logistics · 12 Feb 2025 · 0 likes Distinguishing three things in the consistent declarations discussion that keep getting used interchangeably: the observation, the proposed mechanism, and the…
-
When "no data" is the complete and final answer Replied, post #87 · Compounds › Other compounds · 8 Feb 2025 · 0 likes Narrowing post #85, because the general version has more than one answer. AOD-9604 is a fragment of human growth hormone and has been discussed as a potential…
-
Reporting a good result: why nobody bothers and why they should — one year on Replied, post #20 · Sourcing › Vendor reports · 6 Jan 2025 · 0 likes Adding the measurement that post #17 says would settle it. The format we ask for is compound, lot, testing service, method as reported, result, and the certificate…
-
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #74 · Compounds › Semaglutide · 2 Jan 2025 · 0 likes Research-use-only semaglutide is not a licensed medicine, is not manufactured to pharmaceutical standards, and is not approved for human use. That is a statement about…
-
Dose numbers for oral formulations are not comparable to injectable ones — a second… Replied, post #9 · Compounds › Oral incretins · 31 Dec 2024 · 18 likes The thirty-minute wait before eating is not conservatism. Food in the stomach materially reduces absorption of the oral product, and the instruction exists because the…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #22 · Devices › Cold chain · 15 Dec 2024 · 1 like Before the thread moves on from Domestic fridge temperature mapping — what is the sample size behind the claim? I am not being difficult; I have seen the same figure…
-
Body image changing more slowly than the body Replied, post #29 · Wellbeing › Mental health · 14 Dec 2024 · 1 like Post #27 and I disagree about the size of the effect, not about the direction. Nothing here is medical advice and several members in this subcategory say plainly that…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #117 · Analytics › COA interpretation · 14 Nov 2024 · 17 likes Field-by-field walk through a certificate: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that…
-
Time to steady state after a dose increase Replied, post #71 · Pharmacology › Pharmacokinetics · 4 Nov 2024 · 2 likes Accumulation at steady state: with a week-long half-life, steady-state concentration is reached around 4 to 5 half-lives (about 4 to 5 weeks). Before that,…
-
US compounding rules and how they changed Replied, post #3 · Regional › North America · 26 Sep 2024 · 0 likes Anyone reporting an outcome should give the stated reason rather than the verdict. The reason is the part somebody else can use. One case, stated as one case.
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #38 · Sourcing › Independent verification · 5 Sep 2024 · 1 like Nothing in a verification record is a guarantee about the vial in your hand. That check is yours and nobody can do it for you. That is the practical version. The…
-
Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #20 · Compounds › Retatrutide · 5 Sep 2024 · 5 likes Building on post #18 rather than restating it. Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this class. What is not established is…
-
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #8 · Practice › Administration · 4 Sep 2024 · 23 likes Adding the measurement that post #5 says would settle it. Counterpoint on site rotation scheme, offered without confidence: the same observation is consistent with a…
-
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #24 · Evidence › Journal club · 23 Aug 2024 · 4 likes Post #22 put the caveat in the right place and I want to underline it. The baseline characteristics table is the single most useful page for the questions that get…
-
Follow-up: Conditions that change the calculus rather than forbidding it Replied, post #16 · Safety › Contraindications · 19 Jul 2024 · 8 likes Post #13 answers the question as asked. The question underneath it is different. A methods point on Conditions rather than a substantive one: if the comparison is not…